[1]
2026. RETICULOCYTE HEMOGLOBIN COUNT AS A DIAGNOSTIC MARKER OF FUNCTIONAL IRON DEFICIENCY IN BREAST CANCER PATIENTS IN LAHORE. Journal of Medical & Health Sciences Review. 3, 1 (Jan. 2026), 158–164. DOI:https://doi.org/10.65035/ya2mp577.